BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23681601)

  • 1. Whole-body MR angiography: first experiences with the new TimCT technology with single contrast injection.
    Naguib NN; Bohrt K; Nour-Eldin NE; Schulz B; Tawfik AM; Siebenhandel P; Bodelle B; Eichler K; Moritz A; Vogl TJ; Zangos S
    J Magn Reson Imaging; 2014 Feb; 39(2):434-9. PubMed ID: 23681601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 0.125 mm(3) spatial resolution steady-state MR angiography of the thighs with a blood pool contrast agent using the quadrature body coil only at 1.5 Tesla.
    Boschewitz JM; Hadizadeh DR; Kukuk GM; Meyer C; Wilhelm K; Koscielny A; Verrel F; Gieseke J; Schild HH; Willinek WA
    J Magn Reson Imaging; 2014 Oct; 40(4):996-1001. PubMed ID: 24845363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body MR angiography with body coil acquisition at 3 T in patients with peripheral arterial disease using the contrast agent gadofosveset trisodium.
    Nielsen YW; Eiberg JP; Løgager VB; Hansen MA; Schroeder TV; Thomsen HS
    Acad Radiol; 2009 Jun; 16(6):654-61. PubMed ID: 19297207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body MR angiography in patients with peripheral arterial disease.
    Nielsen YJ
    Dan Med Bull; 2010 Dec; 57(12):B4231. PubMed ID: 21122468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial evaluation of non-contrast-enhanced magnetic resonance angiography in patients with peripheral arterial occlusive disease at 7 T.
    Fischer A; Maderwald S; Johst S; Orzada S; Ladd ME; Umutlu L; Lauenstein TC; Kniemeyer HW; Nassenstein K
    Invest Radiol; 2014 May; 49(5):331-8. PubMed ID: 24637590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body magnetic resonance angiography with additional steady-state acquisition of the infragenicular arteries in patients with peripheral arterial disease.
    Nielsen YW; Eiberg JP; Løgager VB; Just S; Schroeder TV; Thomsen HS
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):484-91. PubMed ID: 19957180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multistation whole-body high-spatial-resolution MR angiography using a 32-channel MR system.
    Nael K; Ruehm SG; Michaely HJ; Saleh R; Lee M; Laub G; Finn JP
    AJR Am J Roentgenol; 2007 Feb; 188(2):529-39. PubMed ID: 17242265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of peripheral contrast-enhanced magnetic resonance angiography at 3.0 Tesla with a hybrid technique: comparison with digital subtraction angiography.
    Berg F; Bangard C; Bovenschulte H; Hellmich M; Nijenhuis M; Lackner K; Gossmann A
    Invest Radiol; 2008 Sep; 43(9):642-9. PubMed ID: 18708858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral magnetic resonance angiography with continuous table movement in combination with high spatial and temporal resolution time-resolved MRA With a total single dose (0.1 mmol/kg) of gadobutrol at 3.0 T.
    Voth M; Haneder S; Huck K; Gutfleisch A; Schönberg SO; Michaely HJ
    Invest Radiol; 2009 Sep; 44(9):627-33. PubMed ID: 19652610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose, time-resolved, contrast-enhanced 3D MR angiography in the assessment of the abdominal aorta and its major branches at 3 Tesla.
    Kramer U; Fenchel M; Laub G; Seeger A; Klumpp B; Bretschneider C; Finn JP; Claussen CD; Miller S
    Acad Radiol; 2010 May; 17(5):564-76. PubMed ID: 20171907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine.
    Klessen C; Hein PA; Huppertz A; Voth M; Wagner M; Elgeti T; Kroll H; Hamm B; Taupitz M; Asbach P
    Invest Radiol; 2007 Sep; 42(9):659-64. PubMed ID: 17700282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [First clinical results in a study of contrast enhanced magnetic resonance angiography with the 1.0 molar gadobutrol in peripheral arterial occlusive disease--comparison to intraarterial DSA].
    Schäfer FK; Schäfer PJ; Jahnke T; Walluscheck K; Priebe M; Hentsch A; Heller M; Brossmann J
    Rofo; 2003 Apr; 175(4):556-64. PubMed ID: 12677513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrafast whole-body MR angiography with two-dimensional parallel imaging at 3.0 T: feasibility study.
    Fenchel M; Doering J; Seeger A; Kramer U; Rittig K; Klumpp B; Claussen CD; Miller S
    Radiology; 2009 Jan; 250(1):254-63. PubMed ID: 19001152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-enhanced MR angiography of renal arteries: comparison with contrast-enhanced MR angiography.
    Angeretti MG; Lumia D; Canì A; Barresi M; Nocchi Cardim L; Piacentino F; Maresca AM; Novario R; Genovese EA; Fugazzola C
    Acta Radiol; 2013 Sep; 54(7):749-56. PubMed ID: 23550187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic performance of contrast-enhanced MR angiography of the aortoiliac arteries with the blood pool agent Vasovist: initial results in comparison to intra-arterial DSA].
    Vogt FM; Herborn CU; Parsons EC; Kröger K; Barkhausen J; Goyen M
    Rofo; 2007 Apr; 179(4):412-20. PubMed ID: 17385136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphasic blood pool contrast agent-enhanced whole-body MR angiography for treatment planning in patients with significant arterial stenosis.
    Huppertz A; Kroll H; Klessen C; Taupitz M; Rückert RI; Schröder RJ; Albrecht T; Frericks B; Voth M; Wagner M; Hamm B; Asbach P
    Invest Radiol; 2009 Jul; 44(7):422-32. PubMed ID: 19448555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced magnetic resonance angiography of the lower extremities: standard-dose vs. high-dose gadodiamide injection.
    Krause U; Kroencke T; Spielhaupter E; Taupitz M; Kenn W; Hamm B; Hahn D
    J Magn Reson Imaging; 2005 Apr; 21(4):449-54. PubMed ID: 15778953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging the whole body atherosclerosis: high resolution magnetic resonance angiography using blood-pool agent. Initial clinical experience.
    Napoli A; Catalano C; Anzidei M; Lanciotti K; Calabrese FA; Cavallo Marincola B; Zini C; Di Paolo PL; Kyventidis T; Passariello R
    Minerva Cardioangiol; 2007 Jun; 55(3):291-301. PubMed ID: 17534247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating peripheral arterial disease with unenhanced quiescent-interval single-shot MR angiography at 3 T.
    Amin P; Collins JD; Koktzoglou I; Molvar C; Markl M; Edelman RR; Carr JC
    AJR Am J Roentgenol; 2014 Apr; 202(4):886-93. PubMed ID: 24660721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of renal artery stenosis with magnetic resonance angiography and stenosis quantification].
    Marchand B; Hernandez-Hoyos M; Orkisz M; Douek P
    J Mal Vasc; 2000 Dec; 25(5):312-320. PubMed ID: 11148391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.